0001309014-12-000344.txt : 20120511 0001309014-12-000344.hdr.sgml : 20120511 20120511060144 ACCESSION NUMBER: 0001309014-12-000344 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120511 FILED AS OF DATE: 20120511 DATE AS OF CHANGE: 20120511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KONINKLIJKE PHILIPS ELECTRONICS NV CENTRAL INDEX KEY: 0000313216 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05146-01 FILM NUMBER: 12832073 BUSINESS ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC BUSINESS PHONE: 31 20 59 77777 MAIL ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS ELECTRONICS N V DATE OF NAME CHANGE: 19930727 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS NV DATE OF NAME CHANGE: 19910903 6-K 1 htm_6797.htm LIVE FILING Koninklijke Philips Electronics N.V. - Form 6-K
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

May 11, 2012

Koninklijke Philips Electronics N.V.
———————————————————————————————————
(Translation of registrant’s name into English)
 
The Netherlands
———————————————————————————————————
(Jurisdiction of incorporation or organization)
 
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
———————————————————————————————————
(Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:  [x] Form 20-F    [ ] Form 40-F
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  [ ]
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  [ ]
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:  [ ] Yes    [x] No
 
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):    n/a 
 

This report comprises a copy of the following press release:

- “Philips updates markets on its Healthcare sector in a meeting with investors
and financial analysts”, dated May 10, 2012.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
    Koninklijke Philips Electronics N.V.
     
Date: May 11, 2012 By: /s/ E.P. Coutinho

  Name:  E.P. Coutinho
  Title: General Secretary
     

EXHIBIT INDEX

Exhibit No.   Description

 
99   Press release
     

EX-99 2 exhibit1.htm EX-99 Exhibit  EX-99

Philips updates markets on its Healthcare sector in a meeting with investors and financial analysts

May 10, 2012

Boston, Massachusetts, USA At a meeting with investors and financial analysts today in Boston, USA, Royal Philips Electronics (NYSE: PHG, AEX: PHI) will update the financial markets on the progress it has made with its change and performance improvement program Accelerate!. This will be followed by a detailed overview of the company’s Healthcare sector.

In addition to the progress on Accelerate!, Philips’ Chief Executive Officer Frans van Houten will update the markets on the actions being taken to achieve the company’s midterm financial targets for 2013. At the event, Mrs. Deborah DiSanzo, who became Chief Executive Officer of Philips Healthcare on May 1, 2012, will update the markets on the sector’s strategy to accelerate profitable growth by creating value through solutions, clinical and business innovations. In addition, executives of the Healthcare team will comment on current market developments and business priorities.

“Our investments in meaningful innovation have resulted in a competitive product and service portfolio, now our task at hand is to drive operational excellence to further accelerate our performance,” said Mrs. DiSanzo.

Presentations in Boston, USA, will start at 8:15 AM local time or 2:15 PM CET. Please visit this link to listen to the webcast and download the presentations that will be shown during the day

For further information, please contact:

Steve Klink
Philips Corporate Communications
Tel.: +31 20 5977415
E-mail: steve.klink@philips.com

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity.” Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.